Family Health: Moderna says COVID-19 vaccine developed for children 6-11 is safe

KLRT Family Health

Moderna says its COVID-19 vaccine is showing a strong immune response in younger children.

In a late-stage clinical trial, the company says its coronavirus vaccine generated virus-neutralizing antibodies in children aged six through 11.

The announcement comes as an FDA panel will vote on whether to authorize Pfizer and BioNTech’s COVID-19 vaccine for children aged five through 11.

Currently, Moderna’s COVID-19 vaccine has only been authorized for use in individuals over 18 years old.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories